Hospital Clinic Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (30)

2024

  1. Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: the STARMEN trial cohort

    Clinical Kidney Journal, Vol. 17, Núm. 8

  2. Sodium-glucose cotransporter 2 inhibition in primary and secondary glomerulonephritis

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 2, pp. 328-340

2023

  1. Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis

    Nefrologia, Vol. 43, Núm. 1, pp. 6-47

  2. Diagnosis and treatment of lupus nephritis: a summary of the Consensus Document of the Spanish Group for the Study of Glomerular Diseases (GLOSEN)

    Clinical Kidney Journal, Vol. 16, Núm. 9, pp. 1384-1402

  3. Effect of Immunosuppressive Treatments on Kidney Outcomes After Gross Hematuria-Related Acute Kidney Injury in Older Patients With IgA Nephropathy

    Kidney International Reports, Vol. 8, Núm. 8, pp. 1596-1604

  4. The coexistence of diabetic retinopathy and diabetic nephropathy is associated with worse kidney outcomes

    Clinical Kidney Journal, Vol. 16, Núm. 10, pp. 1656-1663

2022

  1. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 7, pp. 1270-1280

  2. Saving the kidneys in the lupus patient: Beyond immunosuppression, the need to collaborate across multiple disciplines

    European Journal of Internal Medicine, Vol. 99, pp. 19-21

2020

  1. Risk factors for non-diabetic renal disease in diabetic patients

    Clinical Kidney Journal, Vol. 13, Núm. 3, pp. 380-388

2019

  1. IgA nephropathy in elderly patients

    Clinical Journal of the American Society of Nephrology, Vol. 14, Núm. 8, pp. 1183-1192

  2. Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome

    Kidney International, Vol. 96, Núm. 4, pp. 995-1004

2018

  1. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome

    Kidney International, Vol. 93, Núm. 2, pp. 450-459

  2. Duration of treatment with corticosteroids and recovery of kidney function in acute interstitial nephritis

    Clinical Journal of the American Society of Nephrology, Vol. 13, Núm. 12, pp. 1851-1858

2017

  1. Eculizumab in secondary atypical haemolytic uraemic syndrome

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 466-474

  2. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain

    BioDrugs, Vol. 31, Núm. 3, pp. 239-249

2016

  1. Efectos pleiotrópicos del paricalcitol, más allá del metabolismo óseo-mineral

    Nefrologia

  2. Therapeutic variability in adult minimal change disease and focal segmental glomerulosclerosis

    Clinical Kidney Journal, Vol. 9, Núm. 3, pp. 381-386

2015

  1. An update for atypical haemolytic uraemic syndrome: Diagnosis and treatment. A consensus document

    Nefrologia

  2. Effectiveness of mycophenolate mofetil in C3 glomerulonephritis

    Kidney International, Vol. 88, Núm. 5, pp. 1153-1160

  3. Vitamina D, receptor de la vitamina D e importancia de su activación en el paciente con enfermedad renal crónica

    Nefrologia, Vol. 35, Núm. 1, pp. 28-41